Buy Fresenius
It’s no surprise to find that acquisitions have been long been driving this company’s ambitious growth strategy. Last year, the company spent $367M. (Editor’s note: And, they’ve already well exceeded that for this year!)
Read the full article » | Posted 08-17-2017
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026

